0.48
price up icon2.11%   0.0099
after-market After Hours: .47 -0.01 -2.08%
loading
Xtant Medical Holdings Inc stock is traded at $0.48, with a volume of 128.73K. It is up +2.11% in the last 24 hours and down -6.98% over the past month. Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.4701
Open:
$0.466
24h Volume:
128.73K
Relative Volume:
0.86
Market Cap:
$67.33M
Revenue:
$121.91M
Net Income/Loss:
$1.83M
P/E Ratio:
44.04
EPS:
0.0109
Net Cash Flow:
$7.75M
1W Performance:
+5.29%
1M Performance:
-6.98%
6M Performance:
-22.71%
1Y Performance:
-33.93%
1-Day Range:
Value
$0.46
$0.4825
1-Week Range:
Value
$0.4399
$0.4946
52-Week Range:
Value
$0.438
$0.95

Xtant Medical Holdings Inc Stock (XTNT) Company Profile

Name
Name
Xtant Medical Holdings Inc
Name
Phone
406-388-0480
Name
Address
664 Cruiser Lane, Belgrade, MT
Name
Employee
174
Name
Twitter
@xtantmedical
Name
Next Earnings Date
2026-05-13
Name
Latest SEC Filings
Name
XTNT's Discussions on Twitter

Compare XTNT vs ABT, SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
XTNT icon
XTNT
Xtant Medical Holdings Inc
0.48 65.94M 121.91M 1.83M 7.75M 0.0109
ABT icon
ABT
Abbott Laboratories
87.41 152.88B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
316.48 120.18B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
78.60 100.34B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
57.78 84.95B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
85.78 47.91B 6.30B 1.07B 1.09B 1.8406

Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-05-23 Initiated BTIG Research Buy
Nov-15-18 Reiterated Maxim Group Buy
Feb-14-18 Reiterated Maxim Group Buy

Xtant Medical Holdings Inc Stock (XTNT) Latest News

pulisher
May 24, 2026

XTNT Q1 2026 Earnings: EPS Misses Estimates Despite Stock GainCommunity Hot Stocks - Newser

May 24, 2026
pulisher
May 23, 2026

Xtant Medical Holdings Inc. (XTNT) Q1 2026 Earnings: EPS Misses Estimates Amidst Narrow LossSenior Analyst Forecasts - Newser

May 23, 2026
pulisher
May 22, 2026

Xtant Medical Holdings (XTNT) Edges Higher: Testing Key Resistance at $0.50Shared Buy Zones - Newser

May 22, 2026
pulisher
May 22, 2026

Xtant Medical Holdings Holds Near Key Resistance Level After Modest GainCommunity Chart Signals - Newser

May 22, 2026
pulisher
May 22, 2026

Xtant Medical Holdings (XTNT) Gains 2.08% as Stock Approaches Key Resistance at $0.50Profitability Factor - Newser

May 22, 2026
pulisher
May 20, 2026

Xtant Medical Balances New Growth Bets With Near-Term Pain - TipRanks

May 20, 2026
pulisher
May 19, 2026

Xtant Medical launches pre-shaped bone graft product line By Investing.com - Investing.com Nigeria

May 19, 2026
pulisher
May 18, 2026

XTNT SEC FilingsXtant Medical 10-K, 10-Q, 8-K Forms - Stock Titan

May 18, 2026
pulisher
May 16, 2026

Xtant Medical raises FY 2026 revenue guidance to $101M-$105M as it adds HEMOBLAST distribution rights - MSN

May 16, 2026
pulisher
May 15, 2026

Xtant Medical Q1 Earnings Call Highlights - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

B. Riley Financial | Diversified Financial Services Platform - FinancialContent

May 15, 2026
pulisher
May 15, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

May 15, 2026
pulisher
May 15, 2026

Xtant Medical Holdings’ revenue drops to USD 20.9M in Q1 2026 - Medical Buyer

May 15, 2026
pulisher
May 14, 2026

Xtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2026 Earnings Call Transcript - Insider Monkey

May 14, 2026
pulisher
May 13, 2026

Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 13, 2026
pulisher
May 13, 2026

Xtant Medical Boosts 2026 Outlook Amid Tough Quarter - TipRanks

May 13, 2026
pulisher
May 13, 2026

Xtant Medical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 13, 2026
pulisher
May 13, 2026

Xtant Medical Holdings Inc Q1 2026 Earnings: Revenue Misses $20.9 million - technotrenz.com

May 13, 2026
pulisher
May 13, 2026

Xtant Medical Holdings, Inc. 2026 Q1 10-Q Report: Financial Results, Strategic Initiatives, and Key Risk Factors - Minichart

May 13, 2026
pulisher
May 13, 2026

Xtant Medical Q1 2026 Results: Revenue Guidance Raised, Balance Sheet Strengthened, Exclusive HEMOBLAST® Bellows Distribution Secured 12 - Minichart

May 13, 2026
pulisher
May 13, 2026

Xtant Medical Q1 2026 Earnings Call Transcript - MarketBeat

May 13, 2026
pulisher
May 13, 2026

XTNT: Raised 2026 revenue guidance to $101M–$105M amid new product launches and reduced debt - TradingView

May 13, 2026
pulisher
May 13, 2026

Xtant Medical Reports First Quarter 2026 Results and Raises Guidance - HarianBasis.co

May 13, 2026
pulisher
May 13, 2026

Xtant Medical Hldgs Q1 2026 Earnings Call Transcript - Yahoo Finance

May 13, 2026
pulisher
May 13, 2026

Xtant Medical launches Trivium Shaped allograft for surgeries - MSN

May 13, 2026
pulisher
May 13, 2026

Xtant Medical Updates Q1 Results and Raises 2026 Guidance - TipRanks

May 13, 2026
pulisher
May 13, 2026

XTNT: Q1 2026 revenue dropped 37% and net loss reached $3.1M amid asset sales and reimbursement shifts - TradingView

May 13, 2026
pulisher
May 13, 2026

Xtant Medical (XTNT) Q1 2026 revenue drops 37% as divestitures hit sales - Stock Titan

May 13, 2026
pulisher
May 13, 2026

XTNT: Raised 2026 revenue guidance to $101–$105M amid asset sales, new product launches, and debt reduction - TradingView

May 13, 2026
pulisher
May 13, 2026

Xtant Medical (NYSE: XTNT) cuts debt, raises 2026 revenue guidance after Q1 - Stock Titan

May 13, 2026
pulisher
May 13, 2026

Press Release: Xtant Medical Reports First Quarter 2026 Financial Results - Moomoo

May 13, 2026
pulisher
May 13, 2026

MSN Money - MSN

May 13, 2026
pulisher
May 12, 2026

TradingKey - tradingkey.com

May 12, 2026
pulisher
May 07, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped - Orthopedics This Week

May 07, 2026
pulisher
May 07, 2026

May 13 before trading: Xtant Medical posts Q1 results, 8:30 ET call - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026 - Morningstar

May 07, 2026
pulisher
May 06, 2026

Xtant Medical launches pre-shaped bone graft product line - Investing.com UK

May 06, 2026
pulisher
May 06, 2026

Xtant rolls out ready-to-use bone graft forms for spine surgery - Stock Titan

May 06, 2026
pulisher
May 03, 2026

Xtant Medical Holdings (XTNT) price target increased by 12.12% to 1.26 - MSN

May 03, 2026

Xtant Medical Holdings Inc Stock (XTNT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
ZBH ZBH
$85.50
price up icon 0.22%
STE STE
$216.57
price down icon 1.41%
PHG PHG
$26.95
price down icon 0.74%
$72.10
price up icon 0.28%
$64.23
price down icon 0.16%
EW EW
$85.78
price up icon 3.10%
Cap:     |  Volume (24h):